Role of atypical antipsychotics in rapid cycling bipolar disorder: A review of the literatures

Annals of Clinical Psychiatry

Volumn 23, Issue 2, 2011, Pages 141-149

  Zupancic, Melanie L ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atypical antipsychotics; Rapid cycling; Refractory bipolar disorder

Indexed keywords

ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CLOZAPINE; FLUOXETINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE; TOPIRAMATE; VALPROIC ACID; ZIPRASIDONE; NEUROLEPTIC AGENT;

ADJUVANT THERAPY; CLINICAL GLOBAL IMPRESSION SCALE; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; FOLLOW UP; HOSPITALIZATION; HUMAN; MAINTENANCE THERAPY; MANIA; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOOD CHANGE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RAPID CYCLING BIPOLAR DISORDER; RELAPSE; REVIEW; SIDE EFFECT; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; WEIGHT GAIN; XEROSTOMIA; YOUNG MANIA RATING SCALE; BIPOLAR DISORDER; COMPARATIVE STUDY; DRUG ADMINISTRATION; DRUG RESISTANCE; FEMALE; MALE;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 80052103375     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Chen CK, Shiah I, Yeh CB, et al. Combination treatment of clozapine and topiramate in resistant rapid-cycling bipolar disorder. Clin Neuropharmacol. 2005;28:136-138. (Pubitemid 40923413)
2. Vieta E, Gasto C, Colom F, et al. Treatment of refractory rapid cycling dipolar disorder with risperidone. J Clin Psychopharmacol. 1998;18:172-174. (Pubitemid 28192980)
3. Vieta E, Parramon G, Padrell E, et al. Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord. 2002;4:335-340.
4. Hajek T, Hahn M, Slaney C, et al. Rapid cycling bipolar disorders in primary and tertiary care treated patients. Bipolar Disord. 2008;10:495-502. (Pubitemid 351619165)
5. Tondo L, Hennen J, Baldessarin RJ. Rapid-cycling bipolar disorder: effects of long-term treatments. Acta Psychiatr Scand. 2003;108:4-14. (Pubitemid 36783275)
6. Calabrese JR, Shelton MD, Bowden CL, et al. Bipolar rapid cycling: focus on depression as its hallmark. J Clin Psychiatry. 2001;62(suppl 14):34-41. (Pubitemid 32591416)
7. Calabrese JR, Shelton MD, Rapport DJ, et al. A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. Am J Psychiatry. 2005;162:2152-2161. (Pubitemid 41598271)
8. Muzina DJ, Momah C, Eudicone JM, et al. Aripiprazole monotherapy in patients with rapidcycling bipolar I disorder: an analysis from a long-term, double-blind, placebo-controlled study. Int J Clin Pract. 2008;62:679-687. (Pubitemid 351533679)
9. Suppes T, Ozcan ME, Carmody T. Response to clozapine of rapid cycling versus non-cycling patients with a history of mania. Bipolar Disord. 2004;6:329-332. (Pubitemid 39077095)
10. Calabrese JR, Kimmel SE, Woyshville ML, et al. Clozapine for treatment-refractory mania. Am J Psychiatry. 1996;153:759-764. (Pubitemid 26170535)
11. Frye MA, Altshuler LL, Bitran JA. Clozapine in rapid cycling bipolar disorder. J Clin Psychopharmacol. 1996;16:87-90. (Pubitemid 26060757)
12. Suppes T, Phillips KA, Judd CR. Clozapine treatment of nonpsychotic rapid cycling bipolar disorder: a report of three cases. Biol Psychiatry. 1994;36:338-340. (Pubitemid 24288763)
13. Calabrese JR, Meltzer HY, Markovitz PJ. Clozapine prophylaxis in rapid cycling bipolar disorder. J Clin Psychiatry. 1991;11:396-397.
14. Sanger T, Tohen M, Vieta E, et al. Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling. J Affect Disord. 2003;73:155-161. (Pubitemid 36044643)
15. Gonzalez-Pinto A, Tohen M, Lalaguna B, et al. Treatment of bipolar I rapid cycling patients during dysphoric mania with olanzapine. J Clin Psychopharmacol. 2002;22:450-454.
16. Vieta E, Calabrese JR, Hennen J, et al. Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data. J Clin Psychiatry. 2004; 65:1420-1428.
17. Gianfrancesco F, Rajagopalan K, Goldberg JF, et al. Hospitalization risks in the treatment of bipolar disorder: comparison of antipsychotic medications. Bipolar Disord. 2007;9:252-261. (Pubitemid 46547119)
18. Vieta E, Calabrese JR, Goikolea JM, et al. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized double-blind, placebo-controlled study. Bipolar Disord. 2007;9:413-425. (Pubitemid 46865372)
19. Goldberg JF, Kelley ME, Rosenquist KJ, et al. Effectiveness of quetiapine in rapid cycling bipolar disorder: a preliminary study. J Affect Disord. 2008;105:305-310. (Pubitemid 350245686)
20. Langosch J, Drieling T, Biedermann NC, et al. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate. J Clin Psychopharmacol. 2008;28:555-560.
21. Calabrese JR, Keck PE Jr, Macfadden W, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry. 2005;162:1351-1360. (Pubitemid 40905587)